Rationale of Using Common Antifibrotic Therapy in Post Covid Fibrosis

SM Abdullah Al Mamun; Rowshne Jahan; Quazi tariqul islam; Tahera Nazrin; Kahn shajalal

doi:10.37421/jprm.2020.11.524

Rationale of Using Common Antifibrotic Therapy in Post Covid Fibrosis

Abstract

SM Abdullah Al Mamun*

HTML PDF

Share this article

Journal Highlights

Google Scholar citation report

Citations: 1690

Pulmonary & Respiratory Medicine received 1690 citations as per Google Scholar report

Pulmonary & Respiratory Medicine peer review process verified at publons

Indexed In

Index Copernicus
Google Scholar
Sherpa Romeo
Open J Gate
Genamics JournalSeek
China National Knowledge Infrastructure (CNKI)
Electronic Journals Library
RefSeek
Directory of Research Journal Indexing (DRJI)
Hamdard University
EBSCO A-Z
End Note(Thomson Reuters)
OCLC- WorldCat
SWB online catalog
Virtual Library of Biology (vifabio)
Publons
Geneva Foundation for Medical Education and Research
Euro Pub

Pulmonary & Respiratory Medicine

Rationale of Using Common Antifibrotic Therapy in Post Covid Fibrosis

Abstract

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report

Citations: 1690

Pulmonary & Respiratory Medicine peer review process verified at publons

Indexed In

Related Links

PMC/PubMed Indexed Articles

Open Access Journals